<DOC>
	<DOCNO>NCT02276170</DOCNO>
	<brief_summary>Acute kidney injury ( AKI ) critically ill neonate common associate significant morbidity mortality . No targeted therapeutic treatment strategy establish AKI neonate . Within clinical pharmacokinetic pharmacodynamic conceptual framework , project examine medication aminophylline potential treatment approach AKI .</brief_summary>
	<brief_title>Pharmacology Aminophylline Acute Kidney Injury Neonates</brief_title>
	<detailed_description />
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Aminophylline</mesh_term>
	<criteria>Neonate &lt; 3 month post natal age Diagnosed acute kidney injury ( AKI ) Receiving aminophylline AKI treatment per local standard care . Presence anatomical renal anomaly base postnatal evaluation patient ( hydronephrosis , multicystic kidney , renal agenesis , renal dysplasia , polycystic kidney , obstructive uropathy ) Patient renal replacement therapy Major genetic abnormality ( trisomy 13 , 18 21 ) .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>3 Months</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>